These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats. Alemzadeh R, Holshouser S, Massey P, Koontz J. Eur J Endocrinol; 2002 Jun; 146(6):871-9. PubMed ID: 12039709 [Abstract] [Full Text] [Related]
9. Modification of insulin resistance by diazoxide in obese Zucker rats. Alemzadeh R, Slonim AE, Zdanowicz MM, Maturo J. Endocrinology; 1993 Aug; 133(2):705-12. PubMed ID: 8344209 [Abstract] [Full Text] [Related]
10. Antiobesity effect of diazoxide in obese Zucker rats. Alemzadeh R, Jacobs W, Pitukcheewanont P. Metabolism; 1996 Mar; 45(3):334-41. PubMed ID: 8606640 [Abstract] [Full Text] [Related]
11. The effects of the beta3-adrenoceptor agonist BRL 35135 on UCP isoform mRNA expression. Emilsson V, Summers RJ, Hamilton S, Liu YL, Cawthorne MA. Biochem Biophys Res Commun; 1998 Nov 18; 252(2):450-4. PubMed ID: 9826550 [Abstract] [Full Text] [Related]
12. Trans-10, cis-12-conjugated linoleic acid reduces the hepatic triacylglycerol content and the leptin mRNA level in adipose tissue in obese Zucker fa/fa rats. Gudbrandsen OA, Rodríguez E, Wergedahl H, Mørk S, Reseland JE, Skorve J, Palou A, Berge RK. Br J Nutr; 2009 Sep 18; 102(6):803-15. PubMed ID: 19298684 [Abstract] [Full Text] [Related]
14. The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat. Emilsson V, O'Dowd J, Wang S, Liu YL, Sennitt M, Heyman R, Cawthorne MA. Metabolism; 2000 Dec 18; 49(12):1610-5. PubMed ID: 11145125 [Abstract] [Full Text] [Related]
15. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats. Alemzadeh R, Tushaus K. Med Sci Monit; 2005 Dec 18; 11(12):BR439-48. PubMed ID: 16319780 [Abstract] [Full Text] [Related]
17. Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue. Rouru J, Cusin I, Zakrzewska KE, Jeanrenaud B, Rohner-Jeanrenaud F. Endocrinology; 1999 Aug 18; 140(8):3688-92. PubMed ID: 10433228 [Abstract] [Full Text] [Related]
18. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones. Bing C, King P, Pickavance L, Brown M, Ziegler D, Kaan E, Williams G. Br J Pharmacol; 1999 May 18; 127(1):35-42. PubMed ID: 10369453 [Abstract] [Full Text] [Related]
19. Differential regulation of mouse uncoupling proteins among brown adipose tissue, white adipose tissue, and skeletal muscle in chronic beta 3 adrenergic receptor agonist treatment. Yoshitomi H, Yamazaki K, Abe S, Tanaka I. Biochem Biophys Res Commun; 1998 Dec 09; 253(1):85-91. PubMed ID: 9875224 [Abstract] [Full Text] [Related]
20. Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice. Hioki C, Yoshida T, Kogure A, Takakura Y, Umekawa T, Yoshioka K, Shimatsu A, Yoshikawa T. Horm Metab Res; 2004 Sep 09; 36(9):607-13. PubMed ID: 15486811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]